Toxicological and Pharmacological Evaluation of New Drug Candidates by in Vitro Robotic High-Throughput Cell Assays

Journal of Laboratory Automation

Volumn 9, Issue 3, 2004, Pages 159-162

  Thurow, Kerstin ^a   Entzian, Kristin ^b   Eberlein, Gert ^b  

^a Center for Life Science Automation (celisca)   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

cytostatic agents; cytotoxicity; screening

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CREMOPHOR; CYTOTOXIC AGENT; NEW DRUG; PIPOSULFAN; UNCLASSIFIED DRUG; VINBLASTINE;

ANALYTIC METHOD; ARTICLE; CELL COUNT; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; FLUORESCENCE ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; ROBOTICS;

EID: 3042688320     PISSN: 22110682     EISSN: 15402452     Source Type: Journal    
DOI: 10.1016/j.jala.2004.04.009     Document Type: Article

References (9)

1. Gomez S. G. Bueren J. A. Faircloth G. T. Jimeno J. Albella B. In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells. Exp. Hematol. 2003, 31, 1104–1111.
2. Bunn P. A. Jr. Kelly K. Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer. Clin. Lung. Cancer 2000, 2(Suppl 1), S23–S28.
3. Prijovich Z. M. Chen B. M. Leu Y. L. Chern J. W. Roffler S. R. Anti-tumor activity and toxicity of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in mice. Br. J. Cancer 2002, 86, 1634–1638.
4. Liu Z. Ballinger J. R. Rauth A. M. Bendayan R. Wu X. Y. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres. J. Pharm. Pharmacol. 2003, 55, 1063–1073.
5. Qian J. Zhou C. H. Qian Z. Nan F. J. Ye Q. Z. Development of a K562 cell-based assay for screening anticancer agents. Acta Pharmacol. Sin. 2001, 22, 821–826.
6. Nuijen B. Bouma M. Schellens J. H. Beijnen J. H. Progress in the development of alternative pharmaceutical formulations of taxanes. Invest. New Drugs 2001, 19, 143–153.
7. Krishnadas A. Rubinstein I. Onyuksel H. Sterically stabilized phospholipid mixed micelles: In vitro evaluation as a novel carrier for water-insoluble drugs. Pharm. Res. 2003, 20, 297–302.
8. Badary O. A. Al-Shabanah O. A. Al-Gharably N. M. Elmazar M. A. Effect of cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice. Anticancer Drugs 1998, 9, 809–815.
9. de Vos A. I. Nooter K. Verweij J. Loos W. J. Brouwer E. de Bruijn P. Ruijgrok E. J. Van Der Burg M. E. L. Stoter G. Sparreboom A. Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle cremophor EL. Ann. Oncol. 1997, 8, 1145–1150.